Cerebral imaging and physiopathology of Alzheimer's disease;Imagerie cérébrale et physiopathologie de la maladie d'Alzheimer

Psychologie et NeuroPsychiatrie du Vieillissement

Volumn 5, Issue 4, 2007, Pages 269-279

  Fouquet, Marine ^a   Villain, Nicolas ^a   Chételat, Gaël ^a   Eustache, Francis ^a   Desgranges, Béatrice ^a  

^a CHU CÔTE DE NACRE   (France)

Author keywords

Alzheimer's disease; Amnesic Mild Cognitive Impairment; Hippocampus; Neuroimaging; Posterior cingulate cortex

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN DAMAGE; BRAIN FUNCTION; BRAIN METABOLISM; CINGULATE GYRUS; COGNITIVE DEFECT; DEMENTIA; DISEASE COURSE; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; HUMAN; HYPOTHESIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARIETAL LOBE; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; REST; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TEMPORAL LOBE;

AGED; ALZHEIMER DISEASE; BRAIN; COGNITION DISORDERS; GYRUS CINGULI; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; SEVERITY OF ILLNESS INDEX;

EID: 37149038026     PISSN: 17601703     EISSN: None     Source Type: Journal    
DOI: 10.1684/pnv.2007.0087     Document Type: Review

References (40)

1. Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001 ; 58 : 1985-92.
2. Atiya M, Hyman BT, Albert MS, Killiany R. Structural magnetic resonance imaging in established and prodromal Alzheimer disease : a review. Alzheimer Dis Assoc Disord 2003 ; 17 : 177-95.
3. Chételat G, Baron JC. Early diagnosis of Alzheimer's disease : contribution of structural neuroimaging. Neuroimage 2003 ; 18 : 525-41.
4. Lehéricy S, Marsault C. Les troubles de la mémoire dans la maladie d'Alzheimer : l'apport de l'imagerie cérébrale structurale. In : Ergis AM, Gély-Nargeot MC, Van der Linden M, eds. Les troubles de la mémoire dans la maladie d'Alzheimer. Marseille : Solal, 2005 : 323-56.
5. Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 2005 ; 32 : 486-510.
6. Baron JC, Chételat G, Desgranges B, Perchey G, Landeau B, de la Sayette V, et al. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. Neuroimage 2001 ; 14 : 298-309.
7. Chételat G, Desgranges B, de la Sayette V, Viader F, Eustache F, Baron JC. Mapping gray matter loss with voxel-based morphometry in mild cognitive impairment. Neuroreport 2002 ; 13 : 1939-43.
8. Chételat G, Desgranges B, de la Sayette V, Viader F, Berkouk K, Landeau B, et al. Dissociating atrophy and hypometabolism impact on episodic memory in mild cognitive impairment. Brain 2003 ; 126 : 1955-67.
9. Karas GB, Scheltens P, Rombouts SA, Visser PJ, van Schijndel RA, Fox NC, et al. Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage 2004 ; 23 : 708-16.
10. Chételat G, Landeau B, Eustache F, Mezenge F, Viader F, de la Sayette V, et al. Using voxel-based morphometry to map the structural changes associated with rapid conversion in MCI : a longitudinal MRI study. Neuroimage 2005 ; 27 : 934-46.
11. Matsuda H. Cerebral blood flow and metabolic abnormalities in Alzheimer's disease. Ann Nucl Med 2001 ; 15 : 85-92.
12. Desgranges B, Eustache F. Maladie d'Alzheimer et imagerie fonctionnelle - Mieux comprendre la physiopathologie. Neurologies 2004 ; 7 : 534-9.
13. Chételat G, Desgranges B, Eustache F. Brain profile of hypometabolism in early Alzheimer's disease : relationships with cognitive deficits and atrophy. Rev Neurol (Paris) 2006 ; 162 : 945-51.
14. Chételat G, Desgranges B, de la Sayette V, Viader F, Eustache F, Baron JC. Mild cognitive impairment : can FDG-PET predict who is to rapidly convert to Alzheimer's disease ? Neurology 2003 ; 60 : 1374-7.
15. Chételat G, Eustache F, Viader F, de la Sayette V, Pélerin A, Mézenge F, et al. FDG-PET measurement is more accurate than neuropsychological assessments to predict global cognitive deterioration in patients with mild cognitive impairment. Neurocase 2005 ; 11 : 14-25.
16. Mevel K, Desgranges B, Baron JC, Landeau B, de la Sayette V, Viader F, et al. Detecting hippocampal hypometabolism in Mild Cognitive Impairment using automatic voxel-based approches. Neuroimage 2007 ; 37 : 18-25.
17. Desgranges B, Baron JC, Lalevée C, Giffard B, Viader F, de la Sayette V, et al. The neural substrates of episodic memory impairment in Alzheimer's disease as revealed by FDG-PET : relationship to degree of deterioration. Brain 2002 ; 125 : 1116-24.
18. Greicius MD, Krasnow B, Reiss AL, Menon V. Functional connectivity in the resting brain : a network analysis of the default mode hypothesis. Proc Natl Acad Sci USA 2003 ; 100 : 253-8.
19. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc Natl Acad Sci USA 2001 ; 98 : 676-82.
20. Greicius MD, Menon V. Default-mode activity during a passive sensory task : uncoupled from deactivation but impacting activation. J Cogn Neurosci 2004 ; 16 : 1484-92.
21. Lustig C, Snyder AZ, Bhakta M, O'Brien KC, McAvoy M, Raichle ME, et al. Functional deactivations : change with age and dementia of the Alzheimer type. Proc Natl Acad Sci USA 2003 ; 100 : 14504-9.
22. Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging : evidence from functional MRI. Proc Natl Acad Sci USA 2004 ; 101 : 4637-42.
23. Celone KA, Calhoun VD, Dickerson BC, Atri A, Chua EF, Miller SL, et al. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease : an independent component analysis. J Neurosci 2006 ; 26 : 10222-31.
24. Rombouts SA, Barkhof F, Goekoop R, Stam CJ, Scheltens P. Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease : an fMRI study. Hum Brain Mapp 2005 ; 26 : 231-9.
25. Wang L, Zang Y, He Y, Liang M, Zhang X, Tian L, et al. Changes in hippocampal connectivity in the early stages of Alzheimer's disease : evidence from resting state fMRI. Neuroimage 2006 ; 31 : 496-504.
26. Head D, Buckner RL, Shimony JS, Williams LE, Akbudak E, Conturo TE, et al. Differential vulnerability of anterior white matter in nondemented aging with minimal acceleration in dementia of the Alzheimer type : evidence from diffusion tensor imaging. Cereb Cortex 2004 ; 14 : 410-23.
27. Sydykova D, Stahl R, Dietrich O, Ewers M, Reiser MF, Schoenberg SO, et al. Fiber connections between the cerebral cortex and the corpus callosum in Alzheimer's disease : a diffusion tensor imaging and voxel-based morphometry study. Cereb Cortex 2007 ; sous presse.
28. Xie S, Xiao JX, Wang YH, Wu HK, Gong GL, Jiang XX. Evaluation of bilateral cingulum with tractography in patients with Alzheimer's disease. Neuroreport 2005 ; 16 : 1275-8.
29. Fellgiebel A, Muller MJ, Wille P, Dellani PR, Scheurich A, Schmidt LG, et al. Color-coded diffusion-tensor-imaging of posterior cingulate fiber tracts in mild cognitive impairment. Neurobiol Aging 2005 ; 26 : 1193-8.
30. Kalus P, Slotboom J, Gallinat J, Mahlberg R, Cattapan-Ludewig K, Wiest R, et al. Examining the gateway to the limbic system with diffusion tensor imaging : the perforant pathway in dementia. Neuroimage 2006 ; 30 : 713-20.
31. Muller MJ, Greverus D, Dellani PR, Weibrich C, Wille PR, Scheurich A, et al. Functional implications of hippocampal volume and diffusivity in mild cognitive impairment. Neuroimage 2005 ; 28 : 1033-42.
32. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Weigand SD, O'Brien PC, et al. DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 2005 ; 64 : 902-4.
33. Dickerson BC, Salat DH, Greve DN, Chua EF, Rand-Giovannetti E, Rentz DM, et al. Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD. Neurology 2005 ; 65 : 404-11.
34. Rémy F, Mirrashed F, Campbell B, Richter W. Verbal episodic memory impairment in Alzheimer's disease : a combined structural and functional MRI study. Neuroimage 2005 ; 25 : 253-66.
35. Grady CL, McIntosh AR, Beig S, Keightley ML, Burian H, Black SE. Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer's disease. J Neurosci 2003 ; 23 : 986-93.
36. Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, et al. Patterns of brain activation in people at risk for Alzheimer's disease. N Engl J Med 2000 ; 343 : 450-6.
37. Mondadori CR, Buchmann A, Mustovic H, Schmidt CF, Boesiger P, Nitsch RM, et al. Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years. Brain 2006 ; 129 : 2908-22.
38. D'Esposito M, Deouell LY, Gazzaley A. Alterations in the BOLD fMRI signal with ageing and disease : a challenge for neuroimaging. Nat Rev Neurosci 2003 ; 4 : 863-72.
39. Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, et al. Molecular, structural, and functional characterization of Alzheimer's disease : evidence for a relationship between default activity, amyloid, and memory. J Neurosci 2005 ; 25 : 7709-17.
40. Lockhart A. Imaging Alzheimer's disease pathology : one target, many ligands. Drug Discov Today 2006 ; 11 : 1093-9.